Back

Notification report


Full notification file


General information

Notification Number
B/ES/11/27

Member State to which the notification was sent
Spain

Date of acknowledgement from the Member State Competent Authority
08/06/2011

Title of the Project
Phase I clinical trial to evaluate ICOVIR5 treatment of paediatric refractory or recurrent tumors of the Central Nervous System

Proposed period of release:
01/06/2011 to 30/09/2012

Name of the Institute(s) or Company(ies)
FUNDACION PARA LA INVESTIGACION
BIOMEDICA HOSPITAL UNIVERSITARIO INFANTIL NIÑO JESUS, ;


3. Is the same GMO release planned elsewhere in the Community?
No

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
ICOVIR-5 (HAd5-DM-E2F-K-Δ24-RGD)

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
HAd5Mastadenoviruswildtype human adenovirus (HAd) - Cwildtype human adenovirus (HAd) serotype 5

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known